FIELD: medicine, radionuclide diagnostics in cardiology.
SUBSTANCE: invention can be used to predict the development of a complicated course of the early postoperative period in patients with ischemic cardiomyopathy at the preoperative stage. Echocardiography (EchoCG) is performed and the final systolic volume of the left ventricle (LV systolic volume) is determined. Radionuclide equilibrium ventriculography with 99mTc-pyrophosphate is conducted at rest and against the backdrop of successive intravenous infusions of dobutamine at doses of 5, 10, 15 mcg/kg/min for 5 minutes for each dose. LV Entropy is determined at rest and LV Entropy is determined at the peak of the stress test. The prognostic probability of developing a complicated course of the early postoperative period in patients with ischemic cardiomyopathy (P) is calculated using the following formula: Р=1/(1+e(-(-7.64+2.82*Х-0.23× Y+0.03*Z)) where X is equal to 1 if the patient has an operation on the mitral valve, equals to 0 if the patient does not have an operation on the mitral valve; Y is LV ΔEntropy calculated by the formulaΔ LV Entropy = (LV Entropy at peak stress test - LV Entropy at rest); Z is LV CSR. If the P value is greater than 0.5, the development of complications in the early postoperative period after surgical treatment of ischemic cardiomyopathy is predicted.
EFFECT: method enables to select the patients with an increased risk of developing cardiovascular complications in the early postoperative period due to echocardiographic and radionuclide signs.
1 cl, 2 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING THE RISK OF DEVELOPING REPEATED REMODELING OF THE LEFT VENTRICULAR MYOCARDIUM WITHIN 12 MONTHS AFTER SURGICAL TREATMENT OF ISCHEMIC CARDIOMYOPATHY | 2020 |
|
RU2745473C1 |
METHOD FOR NON-INVASIVE ASSESSMENT OF LEFT VENTRICULAR CONTRACTILITY RESERVE IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY | 2018 |
|
RU2695902C1 |
METHOD FOR PREDICTING EARLY POSTOPERATIVE CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY | 2022 |
|
RU2793654C1 |
METHOD OF PREDICTING EFFECTIVENESS OF DIRECT REVASCULARIZATION PROCEDURE IN PATIENTS WITH CORONARY HEART DISEASE COMPLICATED BY PRONOUNCED DECREASE IN CONTRACTILITY OF LEFT VENTRICLE | 2023 |
|
RU2814402C1 |
METHOD FOR DIAGNOSING THE DEVELOPMENT OF ISCHEMIC CARDIOMYOPATHY IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2021 |
|
RU2765598C1 |
METHOD FOR PREDICTING POST-SURGICAL CARDIAC REMODELING IN PATIENTS AT ISCHEMIC CARDIOMYOPATHY | 2006 |
|
RU2310372C1 |
METHOD FOR PREDICTION OF POSITIVE RESPONSE TO CARDIO-RESYNCHRONIZING THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE OF II AND III FUNCTIONAL CLASS | 2022 |
|
RU2786467C1 |
METHOD FOR PREDICTION OF RESPONSE TO CARDIAC RESYNCHRONIZING THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE | 2019 |
|
RU2721821C1 |
METHOD FOR DETERMINING MITOCHONDRIAL MYOCARDIAL DYSFUNCTION FOLLOWING CARDIAC TRANSPLANTATION USING RADIONUCLIDE METHOD | 2018 |
|
RU2687584C1 |
METHOD OF PREDICTING “SUPER RESPONSE” TO CARDIAC RESYNCHRONIZATION THERAPY IN PATIENTS WITH COMPLETE LEFT BUNDLE BRANCH BLOCK AND CHRONIC HEART FAILURE OF VARIOUS ETIOLOGIES | 2023 |
|
RU2813796C1 |
Authors
Dates
2023-08-02—Published
2022-07-04—Filed